Medicare Advantage plans can’t deny care with AI, CMS warns

The government boiled down its rules about MA plans using AI to make care decisions: Put the circumstances of the individual patient first.

February 7, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | Government warns Medicare Advantage insurers not to deny care based on AI The government boiled down its rules about Medicare Advantage plans using AI to make care decisions: Put the circumstances of the individual patient first. By Casey Ross and Bob Herman STAT+ | Health care developers are impressed by Apple Vision Pro, but they aren't diving head first While health care developers are experimenting with Apple Vision Pro, they say it's too early to understand how it fits into their businesses. By Mario Aguilar STAT+ | Mystery of allergic memory gets closer to answer: a rare group of B cells Two teams' discovery of immune B cells that remember allergens could guide research into new allergy treatments. By Isabella Cueto Mike Reddy for STAT STAT+ | AI can speed up drug discovery but don't expect it to cure cancer, yet AI models promise to identify new disease targets, design better drugs, and improve clinical trials, but experts say major breakthroughs are a long way off. By Casey Ross STAT+ | Years into an addiction crisis, a med school lecture still minimized opioid risks "We've seen what happens when doctors are misled about opioids," said Adriane Fugh-Berman of Georgetown University. By Ed Silverman STAT+ | RayzeBio co-founder, industry veterans launch new biotech VC with $310 million The firm, which plans to launch six or seven biotechs with this first fund, already has four in development. By Allison DeAngelis Adobe Opinion: AI assurance labs intended to test health care technology have an equity problem As leaders across federal agencies swiftly advance regulations for AI in health care, one proposal now seems too big to fail. By Mark P. Sendak and Nicholson Price and Karandeep Singh and Suresh Balu

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser